Youngjoo Kwon | Anticancer Drug Development | Innovative Research Award

Published on | Editorial Board by World Top Scientists

Innovative Research Award

Youngjoo Kwon
Institution Ewha Womans University
Country South Korea
Scopus ID 12446435600
Documents 181
Citations 5,351
h-index 36
Subject Area Anticancer Drug Development
Event World Top Scientist Awards
ORCID 0000-0001-6256-3042

Youngjoo Kwon – Ewha Womans University

Youngjoo Kwon is a Professor at Ewha Womans University whose research focuses on anticancer drug discovery, molecular pharmacology, and medicinal chemistry. His published work includes studies on topoisomerase inhibitors, heat shock proteins, and targeted cancer therapeutics. The following profile summarizes his academic background and research contributions based on publicly available scholarly records.[1]

Abstract

Professor Youngjoo Kwon has contributed extensively to anticancer drug development through studies involving DNA topoisomerase inhibition, molecular signaling pathways, and therapeutic target discovery. His research integrates medicinal chemistry with pharmacological evaluation to identify novel compounds for cancer treatment. Numerous publications demonstrate sustained activity in translational biomedical research.[2]

Keywords

Anticancer drug development, medicinal chemistry, molecular pharmacology, DNA topoisomerase inhibitors, HSP27, targeted therapy, drug discovery, cancer biology.

Introduction

Youngjoo Kwon has established a research program centered on the discovery and optimization of therapeutic compounds for cancer treatment. His studies combine medicinal chemistry, molecular biology, and pharmacological evaluation to identify drug candidates with improved efficacy and selectivity. Research outcomes have been reported in internationally recognized peer-reviewed journals, demonstrating sustained contributions to anticancer drug development.[5]

Research Profile

Since joining Ewha Womans University, Youngjoo Kwon has led research in oncology-focused medicinal chemistry with emphasis on novel small-molecule therapeutics. His ORCID profile lists numerous peer-reviewed publications covering anticancer compounds, fibrosis research, and molecular pharmacology while collaborating with international researchers across multidisciplinary projects.[3]

Research Contributions

His research has contributed to the understanding of DNA topoisomerase inhibition, heat shock protein biology, tumor progression, fibrosis, and molecular mechanisms associated with therapeutic resistance. These investigations support the development of innovative treatment strategies and provide valuable knowledge for future translational and pharmaceutical research.[2]

Publications

Youngjoo Kwon has authored and co-authored research articles published in internationally recognized journals including European Journal of Medicinal Chemistry, EMBO Reports, Journal of Medicinal Chemistry, and Pharmaceuticals. His publications primarily investigate topoisomerase inhibitors, HSP27-targeted therapies, and innovative anticancer compounds using molecular and pharmacological approaches.[4]

Research Impact

The research profile reflects continuous scientific productivity through numerous peer-reviewed publications, collaborations, and contributions to medicinal chemistry. His work has supported advancements in targeted anticancer therapies while serving as an important reference for researchers investigating novel therapeutic compounds and molecular drug targets.[3]

Award Suitability

Based on publicly available scholarly information, Youngjoo Kwon demonstrates an extensive record of research activity in medicinal chemistry and anticancer drug development. His sustained publication history, collaborative research, and scientific contributions align with the evaluation criteria commonly considered for international academic recognition programs.[1]

Conclusion

Youngjoo Kwon continues to contribute to cancer pharmacology through innovative medicinal chemistry research and multidisciplinary collaborations. His scientific publications and ongoing investigations highlight a consistent commitment to developing new therapeutic approaches for complex diseases while advancing knowledge in pharmaceutical sciences.

References

  1. Seo, S. H., Hwang, S. Y., Hwang, S., Han, S., Park, H., Lee, Y. S., Rho, S. B., & Kwon, Y. (2022). Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R. EMBO Reports, 23.
    https://doi.org/10.15252/embr.202152977
  2. Hwang, S. Y., Shrestha, A., Park, S., Bist, G., Kunwar, S., Kadayat, T. M., Jang, H., Seo, M., Sheen, N., Kim, S., Lee, E. S., & Kwon, Y. (2022). Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors. European Journal of Medicinal Chemistry, 227, 113916.
    https://doi.org/10.1016/j.ejmech.2021.113916
  3. Jeon, K. H., Park, S., Jang, H. J., Hwang, S. Y., Shrestha, A., Lee, E. S., & Kwon, Y. (2021). AK-I-190, a new catalytic inhibitor of Topoisomerase II with anti-proliferative and pro-apoptotic activity on androgen-negative prostate cancer cells. International Journal of Molecular Sciences, 22(20), 11246.
    https://doi.org/10.3390/ijms222011246
  4. Yim, J., Lim, H. H., & Kwon, Y. (2021). COVID-19 and pulmonary fibrosis: Therapeutics in clinical trials, repurposing, and potential development. Archives of Pharmacal Research, 44, 499-513.
    https://doi.org/10.1007/s12272-021-01331-9
  5. Kadayat, T. M., Park, S., Shrestha, A., Jo, H., Hwang, S. Y., Katila, P., Shrestha, R., Nepal, M. R., Noh, K., Kim, S. K., Lee, E. S., & Kwon, Y. (2019). Discovery and biological evaluations of halogenated 2,4-diphenyl indeno[1,2-b]pyridinol derivatives as potent Topoisomerase IIΞ±-targeted chemotherapeutic agents for breast cancer. Journal of Medicinal Chemistry, 62(19), 9195-9213.
    https://doi.org/10.1021/acs.jmedchem.9b00970

Mojtaba Ajorloo | Waste Recycling | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Mr.Β  Mojtaba Ajorloo | Waste Recycling | Best Researcher Award

Mojtaba Ajorloo,Β UNSW,Β Australia

Mojtaba Ajorloo is a dedicated individual currently residing in Sydney, NSW. He is associated with UNSW, showcasing his commitment to academic pursuits and professional growth in Australia. With a passion for advancing knowledge, Mojtaba stands out as a promising figure in the academic realm. His contact details include a phone number: +61452572417, and email: mj.ajorloo7@gmail.com. As an active member of the UNSW community, Mojtaba contributes to the academic landscape with enthusiasm and determination. 🌏✨

Profile

linkedin

Google Scholar

EducationΒ 

Currently, Mojtaba is on an academic journey at the University of New South Wales (UNSW), Sydney, Australia, where he is pursuing a Ph.D. in Chemical-Mechanical Engineering with a specialization in Waste-to-Energy. His commitment to exploring innovative solutions for waste management and energy production demonstrates his dedication to sustainable practices. Mojtaba’s academic pursuits, spanning across renowned institutions in Iran and Australia, underscore his passion for advancing the field of Chemical Engineering. πŸŽ“πŸŒπŸ”¬

Skills

Meet Jane, a dynamic professional with a proven track record in project management. πŸš€ Armed with exceptional time management skills, she navigates complex tasks effortlessly, ensuring projects are delivered on schedule. Her robust technical expertise and adeptness in analytical report writing showcase a keen eye for detail and a commitment to excellence. Jane is well-versed in technical and project management standards, demonstrating a dedication to quality and precision in every endeavor. As a team leader, she fosters collaboration and teamwork, driving collective success.

Research Experiences

Meet Mojtaba Ajorloo, a diligent researcher with a passion for sustainability and innovation. 🌱 With a Ph.D. project focused on thermodynamic analysis of waste-to-energy processes at UNSW, Sydney, they’ve showcased expertise in both literature review and experimental design, resulting in published articles and validated thermodynamic models. As a research assistant on industry-funded projects, they’ve excelled in designing experiments, optimizing processes, and meeting rigorous standards, such as ASTM requirements for automotive applications. Their collaborative spirit, technical acumen, and dedication to environmentally conscious solutions make them a valuable asset to any research team. πŸ“šπŸ”¬

Publications Top Notes

  1. “How are the thermal properties of polypropylene/graphene nanoplatelet composites affected by polymer chain configuration and size of nanofiller?”
    • Cited by: 69
    • Year: 2019
  2. “Recent advances in thermodynamic analysis of biomass gasification: a review on numerical modeling and simulation”
    • Cited by: 48
    • Year: 2022
  3. “Incorporation of recycled polypropylene and fly ash in polypropylene-based composites for automotive applications”
    • Cited by: 39
    • Year: 2021
  4. “The role of nanofiller size and polymer chain configuration on the properties of polypropylene/graphite nanoplates composites”
    • Cited by: 18
    • Year: 2020
  5. “Modelling and statistical analysis of plastic biomass mixture co-gasification”
    • Cited by: 17
    • Year: 2022
  6. “Heavy metals removal/stabilization from municipal solid waste incineration fly ash: a review and recent trends”
    • Cited by: 16
    • Year: 2022
  7. “A statistical approach to investigate the effects of multicomponent fractions on the mechanical properties of PP/PPMA/Talc/POE composites”
    • Cited by: 9
    • Year: 2020
  8. “Development of a bubble growth model for natural rubber‐based foams”
    • Cited by: 6
    • Year: 2021
  9. “One-step regulating the microstructure in physical foaming process of polypropylene”
    • Cited by: 4
    • Year: 2020
  10. “Modelling and Statistical Analysis of Plastic Steam Gasification”
    • Year: 2022
  11. “Evaluation of the Usage of Recycled Polypropylene and Fly Ash in Modified Polypropylene-Based Composites Used in Automotive Industry”
    • Year: 2019

 

Kumud Bala | Pharmacology | Outstanding Scientist Award

Published on | Editorial Board by World Top Scientists

Prof Dr. Kumud Bala | Pharmacology | Outstanding Scientist Award

Professor,Β Amity Institute of Biotechnology,Β India

Dr. Kumud Bala is a distinguished academician and currently serves as the Professor and Deputy Dean of Student Welfare at Amity University. πŸŽ“ With a residence at 703 BSES Housing Association, B Block, Plot No-9/17, Sector 62, NOIDA, UP 201 301, Dr. Bala is deeply committed to the well-being and development of students. 🏫 She brings a wealth of knowledge and experience to her role, contributing significantly to the academic community. Dr. Kumud Bala’s contact details include her residential phone number (120) 433 2136 and mobile contact at 98112 92212. πŸ“ž Additionally, she can be reached via email at kumud.bala.singh@gmail.com and kbala@amity.edu. πŸ“§

Profile

scopus

Educational CredentialsΒ 

Dr. Kumud Bala embarked on her academic journey in 1992, earning a B.Sc. in Zoology from Patna University with distinction, securing 71%. πŸŽ“ She continued her pursuit of knowledge, attaining an M.Sc. in Immunology in 1995 with an impressive 65% from the same university. πŸ§ͺ

In 1996, she cleared the B.E.T. (Eligibility for lectureship exam) in Zoology, demonstrating her commitment to academia and qualifying under the UGC. πŸ“š Subsequently, in 1999, Dr. Bala successfully navigated the Research Entrance Test (R.E.T.), a pivotal step leading to her Ph.D. journey in Biotechnology. 🧬

The culmination of her academic endeavors came in 2003 when she was awarded a Ph.D. from Patna University. Her doctoral thesis, titled “Mimosa Pudica and Vinca Rosea Extracts to Reduce Pesticide Induced Toxicity in Bone Marrow and Blood of Mice,” showcased her expertise in biotechnology and dedication to addressing environmental challenges. 🌱

Awards Received

Dr. Kumud Bala’s academic journey is adorned with prestigious recognitions and scholarships. From July 1986 to March 1992, she was a recipient of the Special State Merit Scholarship, a commendable achievement spanning her studies in I Sc., B.Sc., and M.Sc. πŸŽ“ This scholarship reflects her consistent excellence and dedication to her academic pursuits during those years. Subsequently, from April 1999 to March 2003, Dr. Bala was awarded the Teacher’s Fellowship by the UGC, Government of India, supporting her in her pursuit of a Ph.D. πŸ“š This fellowship is a testament to her scholarly endeavors and commitment to advancing knowledge in her field. In recognition of her contributions, she received the Award of Excellence from AIIMS, New Delhi, and PGIMER, Chandigarh, during the period of October 25th to 30th, 2010. πŸ† Her responsibilities included organizing the 10th INPALMS at Amity University, Noida, U.P., showcasing her leadership and organizational skills. These awards and scholarships underscore Dr. Kumud Bala’s commitment to academic excellence, research, and her significant contributions to the field. 🌈

Career Highlights

Since November 1996, Dr. Kumud Bala has been an unwavering force in academia. As a Lecturer at the Department of Zoology, St. Columba’s College, Hazaribagh, she adeptly taught undergraduates and postgraduates in Immunology, Cell and Molecular Biology, Genetics, and Pharmaceutical Biotechnology. πŸ“š Her tenure at Amity University since June 2007 has seen her excel in guiding over 50 students in diverse projects, from Animal Model Development to Drug Targeting through Molecular Modeling. 🌟 Dr. Bala’s dedication extends beyond teaching, encompassing student motivation, career development, and holistic skill enhancement. πŸ’‘

Computer and Technique ProficiencyΒ 

Dr. Kumud Bala seamlessly integrates technology into her professional toolkit, boasting a proficient command of Windows, MS-Office, Internet navigation, HTML, MS Excel, and SPSS. πŸ–₯️ Her adeptness extends further, having completed a Diploma in Advanced Computer Application from NIIT, Patna in 1999, solidifying her tech-savvy credentials. πŸŽ“ This comprehensive skill set empowers her to navigate the digital landscape with ease, enhancing her efficiency in both academic and administrative domains. πŸ’»

Publications Top Notes

πŸ“š 1. Exploring TLR signaling pathways as promising targets in cervical cancer: the road less traveled

πŸ‘¨β€πŸ’Ό Authors: Agarwal, M., Kumar, M., Pathak, R., Bala, K., Kumar, A.

πŸ“… Year: 2024

πŸ“– Journal: International Review of Cell and Molecular Biology

πŸ“š 2. Author Correction: Novel biogenic silver nanoconjugates of Abrus precatorius seed extracts and their antiproliferative and antiangiogenic efficacies

πŸ‘¨β€πŸ’Ό Authors: Kaur, A., Sharma, Y., Singh, G., … Khan, A.A., Bala, K.

πŸ“… Year: 2023

πŸ“– Journal: Scientific Reports

πŸ”— DOI: 10.1038/s41598-023-40079-8

 

πŸ“š 3. Novel biogenic silver nanoconjugates of Abrus precatorius seed extracts and their antiproliferative and antiangiogenic efficacies

πŸ‘¨β€πŸ’Ό Authors: Kaur, A., Sharma, Y., Singh, G., … Khan, A.A., Bala, K.

πŸ“… Year: 2023

πŸ“– Journal: Scientific Reports

πŸ”— DOI: 10.1038/s41598-023-40079-8

πŸ”— Citation:Β  1

πŸ“š 4. Effective seed cake extract of O. sanctum inducing the p53 dependent apoptotic pathway in oral cancer cells

πŸ‘¨β€πŸ’Ό Authors: Sharma, Y., Mishra, R., Kaur, A., Bharadwaj, M., Bala, K.

πŸ“… Year: 2023

πŸ“– Journal: Drug Development and Industrial Pharmacy

πŸ“š 5. Assessing the potential of rosary pea (Abrus precatorius L.) derived aqueous seed extracts as anticancer agents and their phytoconstituents as COX-2 inhibitor: an in-vitro and in-silico approach

πŸ‘¨β€πŸ’Ό Authors: Kaur, A., Singh, G., Sharma, Y., … Kumar, A., Bala, K.

πŸ“… Year: 2023

πŸ“– Journal: Journal of Biomolecular Structure and Dynamics

πŸ”— DOI: Not available

πŸ“š 6. Antiproliferative efficacy of the antioxidant bioactive compounds of defatted seeds of Azadirachta indica and Momordica charantia against the regulatory function of tumor suppressor gene inducing oral carcinoma

πŸ‘¨β€πŸ’Ό Authors: Sharma, Y., Kaur, A., Mishra, R., … Bharadwaj, M., Bala, K.

πŸ“… Year: 2023

πŸ“– Journal: Journal of Biomolecular Structure and Dynamics

πŸ”— DOI: Not available

πŸ“š 7. In-vitro antiproliferative efficacy of Abrus precatorius seed extracts on cervical carcinoma

πŸ‘¨β€πŸ’Ό Authors: Kaur, A., Sharma, Y., Kumar, A., Ghosh, M.P., Bala, K.

πŸ“… Year: 2022

πŸ“– Journal: Scientific Reports

πŸ”— DOI: 10.1038/s41598-022-04122-7

πŸ“š 8. METABOLITES OF ABRUS PRECATORIUS TARGETING MULTIPLE ONCOGENIC AND ONCO-SUPPRESSIVE SIGNALING FOR CANCER PREVENTION AND INTERVENTION

πŸ‘¨β€πŸ’Ό Authors: Kaur, A., Sharma, Y., Kumar, A., Bala, K.

πŸ“… Year: 2022

πŸ“– Journal: Journal of Microbiology, Biotechnology and Food Sciences

πŸ”— DOI: 10.15414/jmbfs.2022.12.2.22-28

πŸ“š 9. Preclinical assessment of stem of Nicotiana tabacum on excision wound model

πŸ‘¨β€πŸ’Ό Authors: Sharma, Y., Kaur, A., Bhardwaj, R., … Madan, S., Bala, K.

πŸ“… Year: 2021

πŸ“– Journal: Bioorganic Chemistry

πŸ”— DOI: 10.1016/j.bioorg.2021.104731

πŸ“š 10. Antioxidant and antimicrobial activity of protein-agnps from the stem of nicotiana tabacum

πŸ‘¨β€πŸ’Ό Authors: Sharma, Y., Srivastava, N., Bala, K.

πŸ“… Year: 2021

πŸ“– Journal: Current Bioactive Compounds

πŸ”— DOI: 10.2174/1573407217999200713101603